Breast Cancer Clinical Trials
415 studies are recruiting for breast cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 12
-
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
This phase I trial studies the side effects and best dose of modified immune cells (IL13Ralpha2 CAR T cells) after a chemotherapy conditioning regimen for the treatment of patients with stage IIIC or IV melanoma or solid tumors that have spread to other places in the body (metastatic). The study ag…
- Stage
- Phase 1
- Ages
- 18 to 75
- Site
- City of Hope, Duarte, California
- Locations
- 3 in total
- Run by
- Anusha Kalbasi
-
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
This is an open-label, single arm, single center, non-randomized feasibility study of the Muse MRgFUS System in subjects with breast cancer. Subjects will undergo partial ablation of half (≤50%) of one of their tumors (if multifocal or multicentric disease) followed by surgical resection per standa…
- Stage
- EARLY_Phase 1
- Ages
- 18 and older
- Site
- Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah
- Run by
- University of Utah
-
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
This is a pilot trial to assess how measures of inflammation are correlated with Social Determinants of Health (SDoH) in breast cancer patients. Expected duration of subject participation is one single time point. The patients will fill out questionnaires and provide a plasma sample.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania
- Run by
- Thomas Jefferson University
-
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- M D Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
The purpose of this study is to provide prospective evidence in the US population of the frequency of skin discoloration and Sentinel Lymph Node detection rate in patients who have recevied Magtrace for Sentinel Lymph Node Biopsy (SLNB) and to evaluate the impact that skin discoloration has on pati…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
- Locations
- 2 in total
- Run by
- Endomagnetics Ltd.
-
Feasibility Study of CBCT for IGRT in Cancer Patients
Cone beam computed tomography (CBCT) is an imaging technology that is incorporated into many modern radiation therapy systems. The quality of conventional CBCT is good enough to align patients for their daily radiation therapy but CBCT images have poor contrast and are susceptible to imaging artefa…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- James Outpatient Center, Columbus, Ohio
- Locations
- 4 in total
- Run by
- Varian, a Siemens Healthineers Company
-
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
This is a phase 2, open-label, singled-arm clinical trial determining efficacy of combination therapy with anastrozole, fulvestrant and abemaciclib in subjects with breast cancer. These are subjects who are newly diagnosed advanced or metastatic hormone receptor positive breast cancer or subjects w…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California
- Run by
- University of California, Irvine
-
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
The investigator and study staff will identify, recruit and randomize Latina participants with elevated genetic and Social Determinants of Heath (SDH) risks. Within 1 week of enrollment, all Latina Aim 1 participants in both study arms will engage in three 30-minute, individual, phone-based session…
- Stage
- Not phased
- Ages
- 30 and older
- Site
- University of Illinois, Chicago, Illinois
- Run by
- University of Illinois at Chicago
-
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
Hot flashes present a considerable problem for many breast cancer patients; these symptoms may be intensified by hormonal therapies, such as aromatase inhibitors or tamoxifen. This study examines the value of solifenacin (a muscarinic acetylcholine receptor antagonist) in reducing hot flashes, comp…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas
- Run by
- University of Arkansas
-
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpos…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Allegheny Health Network, Pittsburgh, Pennsylvania
- Locations
- 18 in total
- Run by
- UMC Utrecht
-
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
The purpose of this study is to see how cancer treatment affects sexual and reproductive function. The patient will also be asked to participate in blood draws to see if and how cancer treatment affects the ovaries and the ability to have children (fertility). These blood draws are optional and the…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
This is a single institution phase II randomized study evaluating the potential benefits of a supplement, tart cherry juice at high- versus low-doses, to prevent taxane induced peripheral neuropathy in breast and ovarian cancer patients undergoing paclitaxel chemotherapy. Eligible participants enro…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- University of California Davis Comprehensive Cancer Center, Sacramento, California
- Run by
- University of California, Davis
-
Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery
This pilot study will examine the impact of pre-operative Medical Reiki© on the psychosocial well-being and recovery of underserved women undergoing breast cancer surgery.
- Stage
- Not phased
- Ages
- 18 to 99
- Site
- Montefiore Medical Center, The Bronx, New York
- Run by
- Albert Einstein College of Medicine
-
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
Breast cancer patients who undergo neoadjuvant systemic therapy and have residual breast cancer identified at the time of surgery exhibit a high (>50%) risk of future life-threatening recurrences and death.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
This is a phase II single-arm, Phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining efficacy of riluzole in preventing cognitive dysfunction in subjects with cancer, who are receiving chemotherapy.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California
- Run by
- University of California, Irvine
-
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
This study is a Phase 1/2, first-in-human, open-label, clinical trial to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of HMBD-501 in patients with advanced-stage, relapsed and/or refractory human epidermal growth factor receptor 3 (HER3)-expressing solid tumors. The st…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Research Site, La Jolla, California
- Locations
- 7 in total
- Run by
- Hummingbird Bioscience
-
Cryoablation vs Lumpectomy in T1 Breast Cancers
This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a method of killing a tumor by freezing it. The standard approach for patients with this kind of cancer is a lumpectomy. This study will review the safety of the cryoabla…
- Stage
- Not phased
- Ages
- 50 and older
- Site
- Washington University School of Medicine, St Louis, Missouri
- Run by
- Washington University School of Medicine
-
FES BPET-DBT in Newly Diagnosed Breast Cancer
Patients with newly diagnosed primary estrogen-receptor (ER) positive breast cancer, with at least one breast lesion that is 1.0 cm in diameter or greater, may be eligible for this study. Patients may participate in this study if they are at least 18 years of age. Up to 20 evaluable subjects will p…
- Stage
- EARLY_Phase 1
- Ages
- 18 and older
- Site
- University of Pennsylvania, Philadelphia, Pennsylvania
- Run by
- Abramson Cancer Center at Penn Medicine
-
Safe and Explainable AI
While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical know…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
- Run by
- Abramson Cancer Center at Penn Medicine
-
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
The investigators propose a randomized controlled clinical trial in 250 women with a history of early stage breast cancer who are overweight or obese with insomnia to test whether a brief, cognitive-behavioral intervention for insomnia (CBT-I) prior to behavioral weight loss (CBT-I+BWL) is superior…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Sibley Memorial Hospital, Washington D.C., District of Columbia
- Locations
- 4 in total
- Run by
- Johns Hopkins University
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Northshore University Health System, Evanston, Illinois
- Locations
- 7 in total
- Run by
- Carevive Systems, Inc.
-
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
The GammaPod machine was made by Xcision Medical Systems and is already FDA cleared to deliver focused radiation within the breast. Unlike current radiation machines, the GammaPod was designed specifically for treating breast cancer. The GammaPod can pinpoint radiation to the tumor bed in the breas…
- Stage
- Not phased
- Ages
- 45 and older
- Site
- UMMC, Baltimore, Maryland
- Locations
- 4 in total
- Run by
- University of Maryland, Baltimore
-
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Earlier detection of disease recurrence will enable greater treatment options and has strong potential to improve patient outcomes. This project is translational and has the potential to lead to future translational research opportunities, including interventional trials in which therapeutic escala…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Washington University School of Medicine, St Louis, Missouri
- Run by
- Washington University School of Medicine
-
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
The purpose of this study is to find out whether adding pembrolizumab, with or without olaparib, to standard radiation therapy is a safe and effective treatment for metastatic breast cancer, , and to see whether the study treatment is better than, the same as, or worse than the usual approach (radi…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients
Patients with breast cancer are commonly treated with taxane chemotherapy. Some very common side effects of taxanes, such as anemia and peripheral neuropathy, are often as not well addressed during treatment, resulting in dose reductions, dose delays and early discontinuation (collectively called r…
- Stage
- Phase 1
- Ages
- 18 to 99
- Site
- University of Florida, Gainesville, Florida
- Run by
- University of Florida
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.